Real-World study tracks quality of life on new myeloma drug combo
Knowledge-focused
Ongoing
This study observes 75 adults with relapsed or refractory multiple myeloma who are already taking selinexor (Nexpovio®) combined with bortezomib and dexamethasone. Researchers track quality of life, side effects, and how well the treatment works in everyday medical practice. The …
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:38 UTC